KRAS and non-small cell lung carcinoma: In both KRAS driven and EGFR driven NSCLC models, we observe that Nrf2 protein abundance (Figure 4D) and activity (Figure 4A,C and Figure S4C,D) are markedly altered between epithelial and mesenchymal cell phenotypes.